Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Thrombocytopenia and CDA[original query]
Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2009 Jan 63 (1): 121-7.
Soo Ross A, Wang Ling Zhi, Ng Swee Siang, Chong Pei Yi, Yong Wei Peng, Lee Soo Chin, Liu Jian Jun, Choo Tai Bee, Tham Lai San, Lee How Sung, Goh Boon Cher, Soong Rich
Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 14 (6): 1797-803.
Tibaldi Carmelo, Giovannetti Elisa, Vasile Enrico, Mey Valentina, Laan Adrie C, Nannizzi Sara, Di Marsico Roberta, Antonuzzo Andrea, Orlandini Cinzia, Ricciardi Simona, Del Tacca Mario, Peters Godefridus J, Falcone Alfredo, Danesi Roma
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
Investigational new drugs 2012 Jun 30 (3): 1164-74.
Oh Do-Youn, Lee Keun Wook, Lee Kyung-Hee, Sohn Chang-Hak, Park Young Suk, Zang Dae Young, Ryoo Hun-Mo, Song Hong-Suk, Kim Jin-Soo, Kang Hye-Jin, Kim Bong-Seog, Bang Yung-J
The impact of CDA A79C gene polymorphisms on the response and hematologic toxicity in gemcitabine-treated patients: a meta-analysis.
The International journal of biological markers 0 29 (3): e224-32.
Li Hui, Wang Xiangling, Wang Xiuw
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.
Leukemia & lymphoma 2017 12 58 (12): 2880-2894.
Megías-Vericat Juan Eduardo, Montesinos Pau, Herrero María José, Moscardó Federico, Bosó Virginia, Martínez-Cuadrón David, Rojas Luis, Rodríguez-Veiga Rebeca, Boluda Blanca, Sendra Luis, Cervera José, Poveda José Luis, Sanz Miguel Ángel, Aliño Salvador
Gene-Gene Interactions of Gemcitabine Metabolizing-Enzyme Genes hCNT3 and WEE1 for Preventing Severe Gemcitabine-Induced Hematological Toxicity.
Journal of clinical pharmacology 2021 5 61 (10): 1376-1385.
Li Juan, Chen Bing, Xi Wen-Qi, Yang Chen, Zhang Wei-X
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel.
The pharmacogenomics journal 2021 Jan .
Vivaldi Caterina, Crucitta Stefania, Catanese Silvia, Cucchiara Federico, Arrigoni Elena, Pecora Irene, Rofi Eleonora, Fornaro Lorenzo, Salani Francesca, Massa Valentina, Vasile Enrico, Morganti Riccardo, Danesi Romano, Del Re Marz
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy.
Cancers 2023 3 15 (5): .
Urtasun Andrea, Olivera Gladys G, Sendra Luis, Aliño Salvador F, Berlanga Pablo, Gargallo Pablo, Hervás David, Balaguer Julia, Juan-Ribelles Antonio, Andrés María Del Mar, Cañete Adela, Herrero María Jo
TOP